Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Or is it the missing CFO formation that happens every year?
Adderalls?
“We’re a serious company and in the future won’t be responding to such questions”…
How do you have any idea what any poster holds? Absolutely clueless.
I’m pointing out the trash that needs to be taken to the curb. Nothing but conspiracy garbage. You’ll realize this one day hopefully.
Saving the quarter each time you post on this board.
Mid-Aug for Q1 (Apr-Jun) if the normal timing holds. They haven’t hired a CFO, which is a huge concern.
Your assumption that all other posters agree is incorrect, but you keep diving into that flawed logic. This board has no impact on the share price. There are just some whiners here that drive everyone crazy.
For example, the link below I assume is Jammy’s as the language and tone used is identical.
http://elitepharmaceuticals.blogspot.com/?m=1
Absolutely 100% correct. I assume you are paid to post after the initial whine.
Stop the conspiracy crap. This is just as bad.
What is the definition of insanity?
Then try reading the transcript or read along while listening.
Completely agree, but a huge failure for CEO if that’s the peak.
Except for the fact Nasrat wouldn’t even break even from where the stock price was when he started 10 years ago. That would be quite the legacy. Long-term shareholders hosed and yet how many millions has he made off Mikah deals and crap sandwich he gave to Elite for millions and millions of shares.
Why would Nasrat act based on your 4 million share ownership ahead of his much larger stake?
Welcome back? That post was from 3 years ago.
We’re 3 weeks away from next cc. Very little is ever divulged during the Q1 call beyond what was laid out during year end call. We’ll be half way through Q2 so will be interesting to see if company is still tracking to 8-9M. Looking forward to seeing impact to margins as overhead has increased on lower sales base. Hoping close to a wash vs pre-Lannett until top line can grow.
Disregard. I see it well below current bid. Hopefully a new floor. Little volume these days.
Do you still see it? I’m not seeing NITE with that big of a bid.
Have had situations when even then it won’t show up and Broker explained that rules are much more lax on OTC. Will be nice when we upgrade to an exchange.
OTC also doesn’t fly by the same rules as exchanges. If you talk to your broker they will say OTC is the Wild West. It is not that uncommon for bid/ask to not show on an order. I’ve had that happen many times, but will still get executed if hits your limit order.
I’m guessing he leads QAnon as well. They are all after ELTP shareholders trying to suppress it for years.
Just because CEO says it doesn’t mean a buyer thinks the same. You need a buyer and a seller. Now would be a terrible time to sell IF the future is bright.
If Oxy ANDA gets rejected, if profitability is uglier than anticipated while R&D pipeline takes its own sweet time would be just a few simple reasons share price would drop. These are realistic, however, so is a potential Oxy filing acceptance for review, Dexcel movement, better IR & ER market penetration, optimizing sales & marketing team, positive BE studies and subsequent filings, etc. Let’s see how creative management can be besides their uncanny ability to keep Mikah around.
Why? There are 2 major options. The company sells now at a much lower price (if it can even find a buyer) or it executes on its strategy. It sounds like we might have a chance for a change at a double or triple vs innings of bunts or getting beaned to get on base only to find out later no one ever crosses home plate. This company has been the slog of slogs, but it’s still alive and self funding along, but yet Mikah is like an unremovable wart that just won’t go away.
You keep ignoring the fact that no one cares about your investment. That is in your head and you keep missing this. No one cares. What people do care about is the BS that’s posted. That’s what people are reacting to.
What is BS, the basics of stock ownership on the OTC or larger fund ownership stabilizes hare price, of which we have none, being on the OTC?
You are pointing out all these issues due to the OTC. There is no analyst coverage (there wouldn’t be at this level of on NASDAQ either as they need to be much larger), there are no large funds buying in, etc. Quit blaming conspiracy theories for what is right there. Just because assets = market cap or revs are close to market cap doesn’t automatically mean the company must be valued as such. Elite has significant risks still (less today than in past) and discounts are factored in.
Bottom line is that you are blaming retail shareholders for not valuing the company appropriately when management keeps us on the OTC. On many days the volume is so light, which means there is no demand, the story is not out there and no one cares at this point other than retail shareholders.
Will things change? I certainly hope so, but with only a couple of tiny ANDAs in FDA review stage I’m skeptical of much movement. Oxy ANDA would be great, but who knows when we’d be able to actually launch even if approved. Not anytime soon. I’d like to see the BE study for the needle movers with an attached filing date . This can help get more RETAIL shareholders excited, but that’s it, unless the company is for sale. We’ll
Also continue the same slow slog until we move to an exchange.
Yes, I pay all the unrealistic hypers and bashers. Nickel per post. Get real dude.
Don’t forget that this is an OTC stock. Fundamentals don’t play nearly as big of a role until it gets on a different exchange. No large active or passively managed funds can touch this stock. It’s simply not an option. This is purely a retail shareholder play with mgmt ownership. When a small fund buys in it is purely speculative for an immaterial amount. These purchases will neither stabilize nor drive the share price up. If we start getting some, as Nasrat calls them, needle movers approved. This is the time to move to a larger exchange with a well-executed IR strategy.
Sort of like the CEO with all the side deals. This is really for the benefit of the company. The optics on this are piss poor, but shareholders should look the other way.
Who owns the shares to stabilize the price? The float is ginormous. This is basic finance dude.
And Santa is dancing with the Tooth Fairy again.
Why ignore over a billion shares outstanding and we’re on the OTC. This is constantly ignored here. There’s no conspiracy. Stock price doesn’t react normal because we’re not on a real exchange. Large fund ownership of a stock can help stabilize and drive the share price north if the fundamentals support it and they are more long term holders. Surprisingly enough, most of the fund ownership today is passively held and has periodic portfolio rotation (ie Blackrocks of world).
I’d agree that they could care less.Everyone has an opinion today in the world of social media. Nothing more.
I don’t really care about your investment. Just don’t post conspiracy theories. It’s pure garbage with no factual truth whatsoever.
Except there isn’t tens of millions shorted of ELTP.
As long as you are ok to be paid in make believe dollars. You get a huge raise each year too with fake healthcare & other benefits.
It’s a retail shareholder conspiracy theory. There is absolutely no truth to it.
Might want to check that math